Le French Gut: Characterization of Gut Microbiota Profiles in France (NCT05758961) | Clinical Trial Compass
RecruitingNot Applicable
Le French Gut: Characterization of Gut Microbiota Profiles in France
France100,000 participantsStarted 2022-09-15
Plain-language summary
" The French Gut " is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project. The main goal of this national trial is a better understanding of the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…).
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Persons over the age of 18 living in France.
* Consent form signed electronically.
Non inclusion Criteria:
* Non-adult person (declarative);
* Person not living in France (declarative);
* Persons subject to a protective measure, in particular under guardianship or curatorship or unable to express their consent (declarative);
* Person having had a colectomy (declarative);
* Person with a digestive stoma (declarative);
* Person who has not signed the consent;
* Person who did not answer the entry questionnaire;
* Person who has not sent a compliant stool sample;
* Antibiotic intake in the 3 months before inclusion (declarative);
* Performing a colonoscopy in the 3 months preceding inclusion (declarative).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Characterize the heterogeneity and diversity of the gut microbiota of subjects living in France
Timeframe: 5 up to 15 years
Trial details
NCT IDNCT05758961
SponsorInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement